Takeda Pharmaceutical
TAK
₹1,247
Share price
0.07%
Change (1 day)
8.70%
Change (1 year)
Categories
Takeda Pharmaceutical (TAK) - Cash on Hand
Cash on Hand as of March 2025 : ₹235.59 Billion
According to Takeda Pharmaceutical's latest financial reports the company has ₹235.59 Billion in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Takeda Pharmaceutical - Cash on Hand chart (from 2008 to 2025)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2024-03-31 | ₹260.38 B | -23.67% |
| 2023-03-31 | ₹341.13 B | -37.47% |
| 2022-03-31 | ₹545.52 B | -17.7% |
| 2021-03-31 | ₹662.84 B | 44.78% |
| 2020-03-31 | ₹457.82 B | 0.9% |
| 2019-03-31 | ₹453.73 B | 97.49% |
| 2018-03-31 | ₹229.75 B | 4.78% |
| 2017-03-31 | ₹219.26 B | -33.52% |
| 2016-03-31 | ₹329.84 B | -10.94% |
| 2015-03-31 | ₹370.35 B | -25.13% |
| 2014-03-31 | ₹494.63 B | 52.93% |
| 2013-03-31 | ₹323.43 B | 14.47% |
| 2012-03-31 | ₹282.55 B | -39.39% |
| 2011-03-31 | ₹466.15 B | 11.06% |
| 2010-03-31 | ₹419.72 B | 7.98% |
| 2009-03-31 | ₹388.71 B | -41.12% |
| 2008-03-31 | ₹660.14 B | 0.04% |
| 2007-03-31 | ₹659.90 B | -7.25% |
| 2006-03-31 | ₹711.52 B | 15.72% |
| 2005-03-31 | ₹614.87 B | 11.6% |
| 2004-03-31 | ₹550.94 B | 19.55% |
| 2003-03-31 | ₹460.83 B | 42.01% |
| 2002-03-31 | ₹324.50 B | 21.79% |
| 2001-03-31 | ₹266.44 B |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | ₹3.377 T | 1,333.41% | 🇺🇸 USA |
 Sanofi SNY | ₹752.83 B | 219.55% | 🇫🇷 France |
 Pfizer PFE | ₹1.507 T | 540.03% | 🇺🇸 USA |
 Novartis NVS | ₹626.62 B | 165.98% | 🇨🇭 Switzerland |
 Seagen
SGEN | ₹107.71 B | -54.28% | 🇺🇸 USA |
 Dr. Reddy's Laboratories RDY | ₹59.00 B | -74.96% | 🇮🇳 India |
 Amgen AMGN | ₹767.17 B | 225.63% | 🇺🇸 USA |
 GlaxoSmithKline GSK | ₹504.63 B | 114.19% | 🇬🇧 UK |
 Merck MRK | ₹803.57 B | 241.08% | 🇺🇸 USA |